Shakir Lakhani
About Shakir Lakhani
Shakir Lakhani serves as the Co-Founder and Chief Technology Officer of Avro Life Sciences, where he focuses on the design and optimization of nanomaterial production systems. He has a background in chemical engineering and has worked extensively in cell culture, cancer research, and product development.
Work at Avro Life Sciences
Shakir Lakhani serves as the Co-founder and Chief Technology Officer at Avro Life Sciences, a position he has held since 2016. His work focuses on the design, optimization, and scale-up of new nanomaterial production systems. He has contributed to the custom design of reactor systems and the development of particle recapture and reuse processes. Lakhani also developed quality control protocols and managed production schedules for various nanomaterial projects, enhancing the efficiency and reliability of the production processes.
Education and Expertise
Shakir Lakhani studied at Upper Canada College from 2009 to 2015, where he developed foundational skills in leadership as Co-president. He then attended the University of Waterloo from 2015 to 2020, earning a Bachelor of Applied Science in Chemical Engineering with a focus on Engineering and Nanotechnology. His academic background is complemented by practical experience in pharmacokinetics and polymer chemistry, as well as proficiency in design software like CAD and SolidWorks, and programming languages including Java, Python, OpenCV, and TensorFlow.
Background
Lakhani's professional journey began with a role as a Research Assistant at the University of Toronto's Mcguigan Lab from 2013 to 2015. He also worked as a Product Development Associate at Validere Technologies for three months in 2016. His early experiences laid the groundwork for his current role at Avro Life Sciences, where he has been instrumental in advancing nanomaterial technologies.
Achievements
During his tenure at Avro Life Sciences, Shakir Lakhani accelerated the translation of H2nanO nanomaterials into a commercial scale product. His work has involved extensive research and development in cell culture and cancer cell lines, utilizing advanced techniques such as qPCR, Western Blotting, and flow cytometry. His contributions have significantly impacted the field of nanotechnology and its applications in life sciences.